Active Ingredient Prescribing
Active Ingredient Prescribing (AIP) will help reduce the cost of medicines, mitigate risk of medication errors and increase health literacy among patients. However, education is essential for both patients and healthcare professionals to ensure a smooth transition and avoid potential risks to patient safety. This was the consensus of four leading health professionals speaking on a panel led by MedicalDirector’s Acting Chief Medical Officer, Dr Charlotte Middleton. The panel explored the AIP changes through multiple lenses, discussing what the changes will mean for patients as well as healthcare professionals.